Home-Mobile

Posted on January 04, 2019, 6:07 am
FavoriteLoadingAdd to favorites 5 mins
The Lead
From An External Source 27, Nov 20 secs
0 20 secs
www.usafricadispatch.com| USA |

The U.S. pharmaceutical firm Merck & Co. has won the first-ever regulatory approval of a vaccine against the Ebola virus, a major boon in the fight against the deadly disease.

The European Commission’s November 10 decision granting a significant step toward full approval of Merck’s Ervebo vaccine, for use by adults over age 18, comes amid an outbreak in the Democratic Republic of the Congo (DRC) that has killed more than 2,100 people since it began last year.

While the approval is for use in the European Union, the vaccine already has been used in the DRC under a “compassionate use”…

MORE ARTICLES IN THIS CATEGORY

Headlines

The Eye of the camera

Editorials and Opinions

Weekly News Roundup

Editor's

Pick

Changing Course: U.S. Making Africa a Priority at the U.N.
/ Oct 29
How is Kelly Knight Craft doing as U.S. permanent representative to the United Nations? It is almost exactly one month since Craft presented her credentials to Secretary-General Antonio Guterres on